Cognitive profile of LRRK2-related Parkinson's disease - Wikidata - awgldk - TriplyDB

Cognitive profile of LRRK2-related Parkinson's disease

Cognitive profile of LRRK2-related Parkinson's disease

http://www.wikidata.org/entity/Q27333093

about

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function Precision Medicine: Clarity for the Complexity of Dementia.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.Cognitive decline in Parkinson disease.Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.Integrating Patient Concerns into Parkinson's Disease Management.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.LRRK2 variation and dementia with Lewy bodies.Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET.The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions

P2860

Q26744716-E823C1A3-83F7-404A-A517-937D8D9B8A1C Q33562458-05D96F36-D4CC-463A-A10C-C2A0EA452E7A Q35568431-E88C9841-1B2C-4B6E-8DEA-647A00799254 Q36581417-06D89D61-B320-4282-9996-4806C5567607 Q36753680-776644C8-8163-4837-8545-616D6EB9257E Q36885946-98E10A1C-BDDC-473B-BE06-4EA9F01257AF Q37141684-1F5671AF-971E-4DE1-83A2-CEB13019C902 Q38376569-D678107E-3007-42FE-AF80-627DE43C1AC1 Q38751099-21CDCA7A-150B-496E-BF41-CFC862FEAEE2 Q38755102-7EBAEE9E-0D01-42FA-BF66-0C3D18C4381B Q39094808-A69B0573-B74C-4BCC-8505-5C1E7E97895E Q39206423-23AD80C3-D477-4EC1-BEE4-3E446E5836C8 Q39841718-C42D8351-C625-40F0-8231-CD02D2A0A170 Q40783163-FDB4F709-7079-4DF8-9E4A-6EEDAD7A007E Q40809659-836861E0-FEBA-4DF0-98C2-DA85B1440633 Q41655722-7B9E5FDA-B381-47E2-8059-B9A6A38A20E8 Q47555107-5F28D754-99C8-4A7D-8B4B-4C59B5BF71DC Q49886566-F0C06CC1-42B6-4FF0-99BB-9CD7A1D66665 Q53397478-4C21D5EC-EFAE-46C0-8070-60983167B615 Q54117121-936D7A73-3575-4DEC-ABE6-5BEFAFC6ACBC Q54982491-8368161D-FDD3-43C4-BD21-15DB1FD8880D Q55287139-EE05B2C3-8FE7-4A62-A112-8793FEA7A7F7 Q57169903-DE276F0D-568A-4D8B-BD13-3D9BCEEC29FB

P2860

Cognitive profile of LRRK2-related Parkinson's disease

http://www.wikidata.org/entity/Q27333093

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cognitive profile of LRRK2-related Parkinson's disease

@ast

Cognitive profile of LRRK2-related Parkinson's disease

@en

Cognitive profile of LRRK2-related Parkinson's disease

@nl

type

label

Cognitive profile of LRRK2-related Parkinson's disease

@ast

Cognitive profile of LRRK2-related Parkinson's disease

@en

Cognitive profile of LRRK2-related Parkinson's disease

@nl

prefLabel

Cognitive profile of LRRK2-related Parkinson's disease

@ast

Cognitive profile of LRRK2-related Parkinson's disease

@en

Cognitive profile of LRRK2-related Parkinson's disease

@nl

P1433

Q27333093-EA66378B-95AD-4FAB-B301-4CF0A338D7D6

P1476

Q27333093-EC11BA09-4FE5-41D1-BCAC-FDC871A556B2

P2093

Q27333093-03CE4E60-7744-4172-AD7A-9DF6B8951A7A

Q27333093-08E4AA00-4541-45C6-B80F-C1F2964D1B01

Q27333093-161B8E5B-B8EE-4EE6-91D5-F4123AF74761

Q27333093-2B03EE68-E77F-43F6-BC9C-C40261B8D8F6

Q27333093-3543AB01-859B-48A0-9132-D329984F3984

Q27333093-467D46FA-7960-42BF-AA9B-B9C537B5BD30

Q27333093-55AF4BA2-9B4A-43B2-8DF3-A6FF16B46CD0

Q27333093-5DB8D2BD-9636-48FD-A4BF-4F8446553304

Q27333093-62F65859-02A0-4848-8A96-5819A73370B2

Q27333093-65240EAA-46E4-4667-B88B-ECE3572535A3

P2860

Q27333093-06EB4DF2-EE59-4360-B888-49270B369DB7

Q27333093-2C46D729-E535-4C60-BBC5-3C3214AC9063

Q27333093-2E3B22AB-98AF-4053-B228-650CAA8AF5A6

Q27333093-31D1B3E4-7EA0-40F3-9F43-1460A4726DDD

Q27333093-36E7E40D-DF71-46B8-A7EA-6337742A94B2

Q27333093-4FF9D0F8-DDA4-4089-893A-C815C50BFC09

Q27333093-58A653D8-570D-4DF4-B865-894D3A379E42

Q27333093-5F99C9B6-B1AA-47CF-B887-EE9A6853BE46

Q27333093-64CA6017-5614-4C16-895B-15B0B50287BE

Q27333093-65480D93-DE6F-4C86-9957-F75E77E4EFCA

P304

Q27333093-0A0BB1A9-ED71-455F-BE54-C75D20BBC9EE

P31

Q27333093-8AD21663-6E23-4F6B-9844-64BED32711FF

P3181

Q27333093-31E00C78-4462-4533-8C9E-61CB42046039

P356

Q27333093-D835D990-629C-457B-8B53-B247801BC9A9

P407

Q27333093-C0A00BCE-EFCD-4C42-B2C0-A591AEDB54E8

P433

Q27333093-C06A2F90-0D26-4853-B02E-B7C27739A56B

P478

Q27333093-76852044-3681-44AB-AA07-C80D5092EC86

P50

Q27333093-03E4B3AE-8DC9-4E69-9BCC-DC93C7205836

Q27333093-1F432CAC-DAD0-46AA-934C-F5E0B7E3B7C6

Q27333093-3AA2D93C-DA1E-4735-AAF7-9D2D558D7A1B

Q27333093-811A628B-2A43-4BD9-8877-F440E1E96C20

Q27333093-B39CDB25-D2EB-44C5-A7AD-180DA45E97C6

Q27333093-C96FD2B4-7849-44CD-8A42-FB76B671ED9F

Q27333093-CC73E7FB-F14D-4740-85E0-1F3E9AAD46B8

Q27333093-E38C6746-849B-4EAE-B6D5-CF3CC258F723

P577

Q27333093-89E09B05-526F-4356-BC98-43387BFD7C27

P5875

Q27333093-3692C0BB-B57F-4131-8A92-5899688B40A8

P698

Q27333093-AA1AC228-5C98-4544-9C50-9810DFE88C56

P921

Q27333093-47AE2405-A6DF-4B04-890A-EC7A165586EC

P932

Q27333093-37265909-4B77-4F6C-8F55-1472863A587E

P3181

P356

P1433

Movement Disorders

P1476

Cognitive profile of LRRK2-related Parkinson's disease

@en

P2093

Alberto J Espay

http://www.w3.org/2001/XMLSchema#string

Amie L Peterson

http://www.w3.org/2001/XMLSchema#string

Brenna Cholerton

http://www.w3.org/2001/XMLSchema#string

Bryan Bernard

http://www.w3.org/2001/XMLSchema#string

Catherine Johnson

http://www.w3.org/2001/XMLSchema#string

Cathy Wood-Siverio

http://www.w3.org/2001/XMLSchema#string

Cyrus P Zabetian

http://www.w3.org/2001/XMLSchema#string

Dennis W Dickson

http://www.w3.org/2001/XMLSchema#string

Fredy J Revilla

http://www.w3.org/2001/XMLSchema#string

Glenn T Stebbins

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Neuropathologic substrates of Parkinson disease dementia.

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming.

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

P304

728-733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1461420

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/MDS.26161

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

Zbigniew K Wszolek

Daniel Weintraub

Stewart A Factor

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272075565

http://www.w3.org/2001/XMLSchema#string

P698

25650144

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4397146

http://www.w3.org/2001/XMLSchema#string